Results 381 to 390 of about 770,455 (417)
Some of the next articles are maybe not open access.
Annals of Internal Medicine, 1990
To review evidence related to sellar masses that might be found incidentally on various radiologic procedures, including their differential diagnosis and recommendations for their evaluation and treatment.An English-language literature search using bibliographic reviews of textbooks and review articles.Articles were selected on the basis of providing ...
Mark E. Molitch, Eric J. Russell
openaire +3 more sources
To review evidence related to sellar masses that might be found incidentally on various radiologic procedures, including their differential diagnosis and recommendations for their evaluation and treatment.An English-language literature search using bibliographic reviews of textbooks and review articles.Articles were selected on the basis of providing ...
Mark E. Molitch, Eric J. Russell
openaire +3 more sources
Current Treatment Options in Neurology, 2009 Pituitary adenomas are the most common intrasellar tumors. With the exception of prolactinomas, first-line treatment is almost always surgical. Prolactinomas are usually treated with dopamine agonists such as cabergoline or bromocriptine. Somatostatin analogues, such as octreotide and lanreotide, can be adjunctive to surgical therapy in acromegaly ...
Roberto Salvatori, Nestoras Mathioudakis
openaire +2 more sources
Journal of the American Medical Association (JAMA), 2000
CONTEXT Evidence suggests that early adverse experiences play a preeminent role in development of mood and anxiety disorders and that corticotropin-releasing factor (CRF) systems may mediate this association.
C. Heim +7 more
semanticscholar +1 more source
CONTEXT Evidence suggests that early adverse experiences play a preeminent role in development of mood and anxiety disorders and that corticotropin-releasing factor (CRF) systems may mediate this association.
C. Heim +7 more
semanticscholar +1 more source
Endocrine Pathology, 1996
Pituitary carcinomas are defined by their metastatic growth. Most of them also invade into surrounding tissues. They should be classified by the site of their metastases (cerebrospinal, systemic, or combined) and by the presumable cell type of origin, respectively with the hormone being demonstrable by immunohistochemistry (adrenocorticotrophic hormone
Wolfgang Saeger, Dorothee Lubke
openaire +3 more sources
Pituitary carcinomas are defined by their metastatic growth. Most of them also invade into surrounding tissues. They should be classified by the site of their metastases (cerebrospinal, systemic, or combined) and by the presumable cell type of origin, respectively with the hormone being demonstrable by immunohistochemistry (adrenocorticotrophic hormone
Wolfgang Saeger, Dorothee Lubke
openaire +3 more sources
Hypothalamus-Pituitary-Thyroid Axis.
Comprehensive Physiology, 2016The hypothalamus-pituitary-thyroid (HPT) axis determines the set point of thyroid hormone (TH) production. Hypothalamic thyrotropin-releasing hormone (TRH) stimulates the synthesis and secretion of pituitary thyrotropin (thyroid-stimulating hormone, TSH),
T. Ortiga-Carvalho +3 more
semanticscholar +1 more source
PITUITARY DEFICIENCY IN PATIENTS WITH PITUITARY TUMOURS
Australasian Annals of Medicine, 1966SUMMARYIn 44 cases of tumours of the pituitary gland, the incidence of pituitary deficiency was determined; eight patients were severely hypopituitary, 16 had partial pituitary deficiency, and in 20 there was no evidence of loss of endocrine function. There was an increased incidence of hypopituitarism in patients with purely chromophobe tumours and in
openaire +3 more sources
Overview of the 2022 WHO Classification of Pituitary Tumors
Endocrine pathology, 2022S. Asa, O. Mete, A. Perry, R. Osamura
semanticscholar +1 more source
Aggressive Pituitary Tumors or Localized Pituitary Carcinomas: Defining Pituitary Tumors
Expert Review of Endocrinology & Metabolism, 2016Pituitary tumors are common and exhibit a wide spectrum of hormonal, proliferative and invasive behaviors. Traditional classifications consider them malignant only when they exhibit metastasis. Patients who suffer morbidity and mortality from aggressive tumors classified as "adenomas" are denied support provided to patients with "cancers" and in many ...
Shereen Ezzat, Sylvia L. Asa
openaire +2 more sources
Invasive Pituitary Adenoma and Pituitary Carcinoma
2001Pituitary adenomas comprise approx 10% of all intracranial tumors. Taking their origin in the anterior lobe, most grow in a slow, expansible manner and are composed of cytologically benign cells resembling those of the normal adenohypophysis. Fully 75% are endocrinologicaly functional, secreting growth hormone (GH), prolactin (PRL), adrenocorticotropic
Peter J. Pernicone, Bernd W. Scheithauer
openaire +2 more sources
Endocrine reviews, 1991
There is considerable, although not entirely consistent, evidence that the hippocampus inhibits most aspects of HPA activity, including basal (circadian nadir) and circadian peak secretion as well as the onset and termination of responses to stress ...
L. Jacobson, R. Sapolsky
semanticscholar +1 more source
There is considerable, although not entirely consistent, evidence that the hippocampus inhibits most aspects of HPA activity, including basal (circadian nadir) and circadian peak secretion as well as the onset and termination of responses to stress ...
L. Jacobson, R. Sapolsky
semanticscholar +1 more source